Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Metformin is less effective in men with early-onset hair loss.

High testosterone increases heart disease risk in women with PCOS.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Oral minoxidil is more convenient but topical minoxidil improves hair density better.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Finasteride in lipid carriers improved hair growth in rats.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Ultrasound boosts finasteride's hair growth effects in mice.

Severe hair loss significantly worsens quality of life.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

Finasteride effectively blocks enzyme causing male pattern baldness.

Some common medications can harm male fertility, but many effects can be reversed.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.